Advanced search
Publication Cover
Journal of Drug Targeting Volume 27, 2019 - Issue 4
Submit an article Journal homepage
368
Views
3
CrossRef citations to date
0
Altmetric
ORGINAL Article

GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models

Jian ZouSchool of Pharmacy, Jinan University, Guangzhou, China; View further author information
,
Zhang ZhangInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China; Correspondence[email protected]
View further author information
,
Fang XuInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China; View further author information
,
Shengyang CuiUniversity of Chinese Academy of Sciences, Beijing, China; ;Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; View further author information
,
Chunli QiInsititute of Laboratory Animal Science, Jinan University, Guangzhou, ChinaView further author information
,
Jinfeng LuoGuangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; View further author information
,
Zhen WangUniversity of Chinese Academy of Sciences, Beijing, China; ;Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; View further author information
,
Xiaoyun LuInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China; View further author information
,
Zhengchao TuSchool of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China; View further author information
,
Xiaomei RenInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China; View further author information
,
Liyan SongSchool of Pharmacy, Jinan University, Guangzhou, China; Correspondence[email protected]
View further author information
&
Ke DingInternational Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education (MOE), School of Pharmacy, Jinan University, Guangzhou, China; ;Guangzhou City Key Laboratory of Precision Chemical Drug Development, School of Pharmacy, Jinan University, Guangzhou, China; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-9016-812XView further author information
ORCID Icon show all
Pages 442-450 | Received 23 Apr 2018, Accepted 05 Oct 2018, Published online: 30 Oct 2018

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marco Emili, Sandra Guidi, Beatrice Uguagliati, Andrea Giacomini, Renata Bartesaghi & Fiorenza Stagni. (2022) Treatment with the flavonoid 7,8-Dihydroxyflavone: a promising strategy for a constellation of body and brain disorders. Critical Reviews in Food Science and Nutrition 62:1, pages 13-50.
Read now

Articles from other publishers (2)

Jie Wang, Yang Zhou, Xia Tang, Xiuwen Yu, Yongjin Wang, Shingpan Chan, Xiaojuan Song, Zhengchao Tu, Zhimin Zhang, Xiaoyun Lu, Zhang Zhang & Ke Ding. (2022) JND4135, a New Type II TRK Inhibitor, Overcomes TRK xDFG and Other Mutation Resistance In Vitro and In Vivo. Molecules 27:19, pages 6500.
Crossref
Francesca Musumeci, Annarita Cianciusi, Ilaria D’Agostino, Giancarlo Grossi, Anna Carbone & Silvia Schenone. (2021) Synthetic Heterocyclic Derivatives as Kinase Inhibitors Tested for the Treatment of Neuroblastoma. Molecules 26:23, pages 7069.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.